These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 17599738)
1. Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: study of 272 cases classified by the 2001 Bethesda system. Thrall M; Kjeldahl K; Gulbahce HE; Pambuccian SE Cancer; 2007 Aug; 111(4):217-23. PubMed ID: 17599738 [TBL] [Abstract][Full Text] [Related]
2. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years. Thrall MJ; Kjeldahl KS; Savik K; Gulbahce HE; Pambuccian SE Cancer; 2005 Aug; 105(4):207-16. PubMed ID: 15900572 [TBL] [Abstract][Full Text] [Related]
3. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers. Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086 [TBL] [Abstract][Full Text] [Related]
4. The clinical significance of benign-appearing endometrial cells on a Papanicolaou test in women 40 years or older. Browne TJ; Genest DR; Cibas ES Am J Clin Pathol; 2005 Dec; 124(6):834-7. PubMed ID: 16416731 [TBL] [Abstract][Full Text] [Related]
5. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria. Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461 [TBL] [Abstract][Full Text] [Related]
6. Significance of benign endometrial cells in Pap smears from postmenopausal women. Wu HH; Schuetz MJ; Cramer H J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479 [TBL] [Abstract][Full Text] [Related]
7. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective. Kapali M; Agaram NP; Dabbs D; Kanbour A; White S; Austin RM Cancer; 2007 Feb; 111(1):26-33. PubMed ID: 17262796 [TBL] [Abstract][Full Text] [Related]
8. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women. Chang A; Sandweiss L; Bose S Gynecol Oncol; 2001 Jan; 80(1):37-43. PubMed ID: 11136567 [TBL] [Abstract][Full Text] [Related]
9. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin. Simsir A; Hwang S; Cangiarella J; Elgert P; Levine P; Sheffield MV; Roberson J; Talley L; Chhieng DC Cancer; 2003 Dec; 99(6):323-30. PubMed ID: 14681938 [TBL] [Abstract][Full Text] [Related]
10. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639 [TBL] [Abstract][Full Text] [Related]
12. Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women. Buccoliero AM; Gheri CF; Castiglione F; Garbini F; Barbetti A; Fambrini M; Bargelli G; Pappalardo S; Taddei A; Boddi V; Scarselli GF; Marchionni M; Taddei GL Cytopathology; 2007 Aug; 18(4):241-9. PubMed ID: 17559564 [TBL] [Abstract][Full Text] [Related]
13. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System. Bean SM; Connolly K; Roberson J; Eltoum I; Chhieng DC Cancer; 2006 Feb; 108(1):39-44. PubMed ID: 16329117 [TBL] [Abstract][Full Text] [Related]
14. Normal-Appearing Endometrial Cells in Pap Tests of Women Aged Forty Years or Older and Cytohistological Correlates. Izadi-Mood N; Sarmadi S; Sanii S; Sadidi H Acta Cytol; 2015; 59(2):175-9. PubMed ID: 25924690 [TBL] [Abstract][Full Text] [Related]
15. Histologic implications of Pap smears classified as atypical glandular cells. Haidopoulos DA; Stefanidis K; Rodolakis A; Pilalis A; Symiakaki I; Diakomanolis E J Reprod Med; 2005 Jul; 50(7):539-42. PubMed ID: 16130853 [TBL] [Abstract][Full Text] [Related]
16. [Thr role of histiocytes in the cytodiagnosis of endometrial adenocarcinoma]. Zarcone R; Cardone G; Voto RI; Longo M; Cardone A Minerva Ginecol; 1992 Mar; 44(3):83-6. PubMed ID: 1565286 [TBL] [Abstract][Full Text] [Related]
17. Endometrial carcinoma detected with SurePath liquid-based cervical cytology: comparison with conventional cytology. Patel C; Ullal A; Roberts M; Brady J; Birch P; Bulmer JN; Wadehra V Cytopathology; 2009 Dec; 20(6):380-7. PubMed ID: 19207308 [TBL] [Abstract][Full Text] [Related]
18. Detection of chromosomal anomalies in endometrial atypical hyperplasia and carcinoma by using fluorescence in situ hybridization. Qian J; Weber D; Cochran R; Hossain D; Bostwick DG Cancer Cytopathol; 2010 Apr; 118(2):97-104. PubMed ID: 20225199 [TBL] [Abstract][Full Text] [Related]
19. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study. Schorge JO; Hossein Saboorian M; Hynan L; Ashfaq R Cancer; 2002 Dec; 96(6):338-43. PubMed ID: 12478681 [TBL] [Abstract][Full Text] [Related]
20. Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study. Kipp BR; Medeiros F; Campion MB; Distad TJ; Peterson LM; Keeney GL; Halling KC; Clayton AC Cancer; 2008 Aug; 114(4):228-35. PubMed ID: 18548528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]